Table 2.

Post-transplant complications

Complication	Number (%)
Toxicity
Sinusoidal obstructive syndrome	1 (2%)
Diffuse alveolar hemorrhage	2 (5%)
Thrombotic microangiopathy	2 (5%)
Graft versus host disease
Grades II–IV acute GVHD	4 (10%)
Grades III–IV acute GVHD	1 (2%)
Chronic GVHD	3 (7%)
Viral infections or viremias
Cytomegalovirus	11 (27%)
Epstein-Barr virus	4 (10%)
Adenovirus	3 (7%)
BK virus	1 (2%)
Norovirus	3 (7%)
Autoimmune complications
Immune thrombocytopenia	2 (5%)
Autoimmune hemolytic anemia	3 (7%)
Guillain-Barre syndrome	2 (5%)
Graft failure
Primary graft failure	1 (2%)
Secondary graft failure	2 (5%)
Mixed chimerism
Mixed chimerism	24 (59%)
Donor myeloid chimerism < 90%*	3 (9%)
Donor T cell chimerism < 75%*	7 (21%)

^*At 1-year post-transplant in patients with event-free survival (n = 33)